Skip to main content

Advertisement

Table 2 Prevalence of pfcrt 76 polymorphisms in pre-treatment samples in different categories of CQ treatment outcomes

From: Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications

  Treatment outcome
Type of pfcrt-76 polymorphism ACPR (%) ETF (%) LCF (%) LPF (%) All (%)
Pfcrt-T76 mutant-type 42 (95.5) 23 (100) 15 (100) 29 (96.7) 109 (97.3)
Pfcrt-K76 wild-type 2 (4.5) 0 0 0 2 (1.8)
Pfcrt-T76/K76 mixed-type 0 0 0 1 (3.3) 1 (0.9)
Total (%) 44 (100) 23 (100) 15 (100) 30 (100) 112 (100)